01 Mening Poehling 508

Document text

National Center for Immunization & Respiratory Diseases
ACIP Meningococcal Vaccines Work Group 
Introduction
Katherine Poehling, MD, MPH
Work Group Chair
June 23, 2023

2Meningococcal Vaccines Work Group
▪ ACIP Members on the WG
–Kathy Poehling (Chair)
–Lynn Bahta
–Jamie Loehr
▪ Ex Officio WG Members
–Margaret Bash (FDA)
–Mark Connelly (FDA)
–Francisco Leyva (NIH)
▪ WG Liaisons and Consultants
–Amra Resic (AAFP)
–Samir Shah (AAP) 
–Sharon McMullen (ACHA)
–Cacky Tate (AIM)
–Paul Cieslak (CSTE)
–Kathy Hsu (IDSA)
–Joseline Zafack (NACI)
–Jeff Goad (NFID)
–Jessica Cataldi (PIDS)
–Amy Middleman (SAHM)
–David Stephens (Emory)▪ CDC Contributors
–Jenn Collins (DBD/NCIRD)
–Lucy McNamara (DBD/NCIRD)
–LeAnne Fox (DBD/NCIRD)
–Susan Hariri (DBD/NCIRD)
–Amy Rubis (DBD/NCIRD)
–Noele Nelson (DBD/NCIRD)
–Alison Albert (DBD/NCIRD)
–Angela Jiles (DBD/NCIRD)
–Jonathan Duffy (DHQP/NCEZID)
–Tanya Myers (DHQP/NCEZID) 
–Ismael Ortega -Sanchez (DVD/NCIRD)
–Liz Velazquez (ISD/NCIRD)
–Jessica MacNeil (ACIP Secretariat)
▪ GRADE/EtR Support
–Doug Campos -Outcalt (Arizona)
–Rebecca Morgan (Case Western Reserve)
3February ACIP Meeting Recap
▪
▪
▪Epidemiology of meningococcal disease in the United States
Pfizer’s MenABCWY vaccine clinical trials data
Work Group interpretation of Pfizer’s MenABCWY trials data
4Summary of Recent Work Group Activities Involving Pfizer Vaccine
▪
▪Pfizer and CDC staff presented their cost effectiveness models for Pfizer’s 
pentavalent vaccine
Work group members reviewed GRADE and EtR findings for Pfizer’s vaccine 
and deliberated about what to propose to ACIP
5Agenda for Today
▪
–
▪
–CDC’s cost effectiveness model
Dr. Ismael Ortega -Sanchez, CDC
Work group’s GRADE/EtR assessment results
Dr. Sam Crowe, CDC